Regional Non-comparative Prospective Study of the Impact of Gamma Knife Radiosurgery on Tremor in Multiple Sclerosis
NCT03339908 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2023-04-06
Summary
Multiple sclerosis, chronic inflammatory disease of the central nervous system, affects approximately 100,000 peoples in France. It is the leading cause of disability in young adults. Tremor is a common symptom (25-58% of patients depending on the series) and can be particularly disabling. The drug treatments against tremor are ineffective or insufficient. Deep brain stimulation of the Vim (Small nucleus within thalamus) and stereotactic radiofrequency thalamotomy have shown their efficacy in this indication. However, in some cases these invasive procedures are impossible because of operational risk. Gamma knife thalamotomy can be an alternative choice. This procedure, less invasive, mainly because of the absence of craniotomy is used by several teams of international reputation for over fifteen years, with good to excellent results in essential tremor. The team of Marseille, which has an experience of 22 years in Gamma Knife radiosurgery has treated 250 patients with severe tremor (essential tremor or Parkinson's disease) by a unilateral thalamotomy with an improvement of 70% of functional scores.
In the literature, no formal studies of the effect of Gamma Knife in Multiple Sclerosis (MS) tremor is reported. There are only a few cases without specific evaluation of the efficacy in this disease. Hence the importance of studying in detail the effects of this technique, which allows a precise and limited lesion volume. Using an isocenter of 4mm and a dose of 130 Gy radiation lesion obtained is limited to a volume of 200 to 500 mm3.
The aim of this study is to assess through a minimally invasive technique with a circumscribed and reproducible lesion volume, the effect of thalamotomy on the particular tremor in multiple sclerosis with a prospective evaluation of its effects.
Patients with MS with a disabling tremor will be included in the study. They will be assessed with neurological examination, quality of life scales, neuropsychological assessment, functional scores and cerebral MRI.
This study will demonstrate the feasibility and effectiveness of Gamma Knife thalamotomy in MS patients with severe tremor.
Conditions
Interventions
- DEVICE
-
Thalamotomy by gamma Knife radiosurgery
The surgical procedure consists of a very partial radiation of the brain with stereotaxic precision
Sponsors & Collaborators
-
Assistance Publique Hopitaux De Marseille
lead OTHER
Principal Investigators
-
Jean-Marie REGIS, PU-PH · Assistance Publique Hôpitaux de Marseille
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-23
- Primary Completion
- 2021-01-20
- Completion
- 2023-04-04
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis
NCT04220814 ·Status: COMPLETED ·Phase: NA
-
Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
NCT01392872 ·Status: COMPLETED ·Phase: NA
-
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160 ·Status: NOT_YET_RECRUITING
-
Fingolimod Real World Experience: the French Grand-Est Cohort
NCT02799199 ·Status: COMPLETED
-
Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis
NCT03239860 ·Status: TERMINATED ·Phase: PHASE2
-
EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients
NCT02117375 ·Status: UNKNOWN ·Phase: NA
-
Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up
NCT00289159 ·Status: UNKNOWN
-
Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion
NCT02043964 ·Status: COMPLETED ·Phase: NA
-
Multi-center Database Registry to Study Thalamus Changes Using AI in MS
NCT03920995 ·Status: COMPLETED
-
Upper Limbs Intervention in Multiple Sclerosis
NCT02047825 ·Status: COMPLETED ·Phase: NA
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
NCT02994121 ·Status: RECRUITING
-
Evaluation of the Reproducibility of the Measurement of the QSM Signal (Quantitative Susceptibility Mapping)
NCT04465448 ·Status: TERMINATED
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients
NCT02142764 ·Status: COMPLETED ·Phase: NA
-
Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis
NCT04201470 ·Status: COMPLETED ·Phase: NA
-
Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity
NCT07292480 ·Status: RECRUITING ·Phase: NA
-
Immersive Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis
NCT05320237 ·Status: COMPLETED ·Phase: NA
-
The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis
NCT06599307 ·Status: RECRUITING ·Phase: PHASE2
-
Multiple Sclerosis in the Elderly: Epidemiology, Clinical and MRI Characteristics
NCT03854123 ·Status: COMPLETED
-
Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)
NCT04289909 ·Status: COMPLETED ·Phase: NA
-
Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study
NCT03624296 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Neurodegenerative Process Within Visual Ways In Multiple Sclerosis
NCT03656055 ·Status: COMPLETED
-
Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis
NCT01435993 ·Status: TERMINATED ·Phase: PHASE1
-
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
NCT05491031 ·Status: RECRUITING ·Phase: NA
-
Advanced MRI Measures of Repair in Alemtuzumab Treated Patients
NCT01307332 ·Status: COMPLETED ·Phase: PHASE3